Eli Lilly, Novo Nordisk and the FDA met in June of last year to discuss how to make insulin bottles more distinguishable for the visually impaired. Participants agreed that a coding system using horizontal raised bars would be the most effective. If the FDA accepts the plan, the four code categories will be as follows: one bar for rapid-acting insulin analogs, two bars for regular insulins, three bars for insulin mixtures and four bars for intermediate- and long-acting insulins.
“The new coding system should only raise the price of the bottles by a few cents,” says Ed Bryant, editor of Voice of the Diabetic and participant in June’s meeting. “FDA approval of the system is expected,” adds Bryant.